Correlation Between Cardio Diagnostics and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Emergent Biosolutions, you can compare the effects of market volatilities on Cardio Diagnostics and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Emergent Biosolutions.
Diversification Opportunities for Cardio Diagnostics and Emergent Biosolutions
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cardio and Emergent is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Emergent Biosolutions
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 1.35 times more return on investment than Emergent Biosolutions. However, Cardio Diagnostics is 1.35 times more volatile than Emergent Biosolutions. It trades about 0.08 of its potential returns per unit of risk. Emergent Biosolutions is currently generating about 0.07 per unit of risk. If you would invest 28.00 in Cardio Diagnostics Holdings on September 5, 2024 and sell it today you would earn a total of 2.00 from holding Cardio Diagnostics Holdings or generate 7.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardio Diagnostics Holdings vs. Emergent Biosolutions
Performance |
| Timeline |
| Cardio Diagnostics |
| Emergent Biosolutions |
Cardio Diagnostics and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardio Diagnostics and Emergent Biosolutions
The main advantage of trading using opposite Cardio Diagnostics and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.| Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
| Emergent Biosolutions vs. Candel Therapeutics | Emergent Biosolutions vs. Cingulate Warrants | Emergent Biosolutions vs. Unicycive Therapeutics | Emergent Biosolutions vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |